nasal type and aggressive NK-cell leukemia by the WHO classification. Clinically, NK-cell lymphomas can be divided into nasal, non-nasal and aggressive leukemia/lymphoma subtypes. Clinical ...

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...

are already being successfully applied in the treatment of leukemia. Another type of killer cell that is now also being used are the so-called natural killer cells (NK). Rather than recognizing ...

Due to its aggressive nature and the immature cell involvement, the prognosis can be poor if not treated promptly,” said Marina Konopleva, MD, Phd, Professor, Molecular Pharmacology, Director, ...